RGD-Modified Nano-Liposomes Encapsulated Eptifibatide with Proper Hemocompatibility and Cytotoxicity Effect

BACKGROUND: Eptifibatide (Integrilin®) is a hepta-peptide drug which specifically prevents the aggregation of activated platelets. The peptide drugs are encapsulated into nanolipisomes in order to decreasing their side effects and improving their half-life and bioavailability. OBJECTIVES: In this st...

Descripción completa

Detalles Bibliográficos
Autores principales: Bardania, Hassan, Shojaosadati, Seyed Abbas, Kobarfard, Farzad, Morshedi, Dina, Aliakbari, Farhang, Tahoori, Mohammad Taher, Roshani, Elahe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Institute of Genetic Engineering and Biotechnology 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6697844/
https://www.ncbi.nlm.nih.gov/pubmed/31457055
http://dx.doi.org/10.21859/ijb.2008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6697844/
https://www.ncbi.nlm.nih.gov/pubmed/31457055
http://dx.doi.org/10.21859/ijb.2008

Ejemplares similares